SCHEMBL7103584

SCHEMBL7103584

CN(Cc1cnc(CN(C)CC(CO)CO)cn1)CC(CO)CO

nearest known ligand 0.44

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PNP P00491 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7108600 0.85 TYMP (0.41) PNP
SCHEMBL7106657 0.83 PNP (0.39) PNP
SCHEMBL7110095 0.83 MTAP (0.34) PNP
SCHEMBL7652140 0.83 PNP (0.39) PNP
SCHEMBL7105228 0.82 PNP (0.33) PNP
SCHEMBL7107855 0.75 HSD17B10 (0.47) PNP
SCHEMBL7654981 0.73 PNP (0.41) PNP
SCHEMBL7103634 0.73 APLNR (0.31)
SCHEMBL7658936 0.70 KMT2A (0.45)
SCHEMBL7650963 0.69 KMT2A (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1001944-B1 PYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM AVENTIS PHARMA SA (FR) 2003-10-01 EP claimed
US-6399613-B1 N,N'-BIS(2-HYDROXYETHYL)PYRAZINE-2,5- OR -2,6-DICARBOXAMIDE; DIABETES AVENTIS PHARMA S.A. (FR) 2002-06-04 US claimed
US-6399613-B1 N,N'-BIS(2-HYDROXYETHYL)PYRAZINE-2,5- OR -2,6-DICARBOXAMIDE; DIABETES AVENTIS PHARMA S.A. (FR) 2002-06-04 US disclosed